Previous close | 3.7000 |
Open | 4.9000 |
Bid | 3.3000 |
Ask | 6.2000 |
Strike | 160.00 |
Expiry date | 2025-12-19 |
Day's range | 3.1000 - 4.9000 |
Contract range | N/A |
Volume | |
Open interest | 4.77k |
Blueprint Medicines is Tuesday's IBD Stock Of The Day. Shares are breaking a trendline, giving investors an early entry within a flat base.
On June 5, 2024, Percy Carter, Chief Scientific Officer of Blueprint Medicines Corp (NASDAQ:BPMC), sold 4,000 shares of the company.
On June 4, 2024, L. Hewes, Chief Medical Officer of Blueprint Medicines Corp (NASDAQ:BPMC), sold 2,424 shares of the company.